The Effect of Antiretroviral Therapy on the Lipid Profile of AIDS Patients in Maracaibo, State of Zulia, Venezuela

A prospective study was carried out to determine the effect of antiretroviral therapy on the lipid profile in a population of 50 patients with AIDS who received their first antiretroviral drug treatment in the HIV-AIDS clinic at the Maracaibo University Hospital from November 2008 to July 2009. Seru...

Full description

Bibliographic Details
Main Authors: Isabel Soto, María Villalobos, Rafael Villalobos
Format: Article in Journal/Newspaper
Language:English
Spanish
Published: Universidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y Tropicales 2010
Subjects:
Online Access:https://doaj.org/article/4f16401efe5e4439a4c87902a0b122a1
Description
Summary:A prospective study was carried out to determine the effect of antiretroviral therapy on the lipid profile in a population of 50 patients with AIDS who received their first antiretroviral drug treatment in the HIV-AIDS clinic at the Maracaibo University Hospital from November 2008 to July 2009. Serum levels of cholesterol, triglycerides, HDL-cholesterol and LDL-cholesterol were determined at the beginning and the end of the study. The therapeutic combinations were: 47 patients (94.0%) with the protease/booster inhibitors (IP/b) + nucleoside inhibitors of reverse transcriptase (NRTI) and 3 (6%)with 2NRTI + 1 non-nucleoside inhibitors of reverse transcriptase inhibitors (NNRTIs). Initially, lipid profile parameters were inside the range of normality. By the end of the study, blood levels for triglycerides, total cholesterol and LDLc had increased with regard to the initial values. Conclusions are that hypertriglyceridemia is a frequent alteration in patients that receive antiretroviral therapy with PI/b combined with NRTI, since this constituted most of the sample studied.